Product
α-adrenergic receptor agonist
Aliases
norepinephrine, Vasopressors
6 clinical trials
2 indications
Indication
Adverse EffectIndication
OutcomeClinical trial
90% Effective Dose of Norepinephrine Infusions for Preventing Postspinal Anesthesia Hypotension Under Intensive and Standard Treatment in Preeclamptic Patients During Cesarean SectionStatus: Not yet recruiting, Estimated PCD: 2025-06-30
Clinical trial
90% Effective Dose of Phenylephrine Infusions for Preventing Postspinal Anesthesia Hypotension Under Intensive and Standard Treatment During Cesarean SectionStatus: Not yet recruiting, Estimated PCD: 2025-06-30
Clinical trial
Intensive Versus Standard Treatment for Spinal Anesthesia-induced Hypotension on Neonatal Outcomes in Preeclamptic Patients During Cesarean SectionStatus: Recruiting, Estimated PCD: 2024-06-30
Clinical trial
Intensive Versus Standard Treatment for Spinal Anesthesia-induced Hypotension on Maternal Hemodynamics During Cesarean Section: A Multicenter, Prospective, Single-blind, Randomized, Controlled TrialStatus: Not yet recruiting, Estimated PCD: 2025-12-31
Clinical trial
90% Effective Dose of Norepinephrine Infusions for Preventing Postspinal Anesthesia Hypotension Under Intensive and Standard Treatment During Cesarean SectionStatus: Not yet recruiting, Estimated PCD: 2025-03-31
Clinical trial
90% Effective Dose of Phenylephrine Infusions for Preventing Postspinal Anesthesia Hypotension Under Intensive and Standard Treatment in Preeclamptic Patients During Cesarean SectionStatus: Not yet recruiting, Estimated PCD: 2025-12-31